Steripet 250 MBq/ ml Norge - norsk - Statens legemiddelverk

steripet 250 mbq/ ml

ge healthcare b.v. - fludeoksyglukose (18f) - injeksjonsvæske, oppløsning - 250 mbq/ ml

Teceos 13 mg Norge - norsk - Statens legemiddelverk

teceos 13 mg

cis bio international - butedronatetetranatrium - preparasjonssett til radioaktive legemidler - 13 mg

Venticoll 0.5 mg Norge - norsk - Statens legemiddelverk

venticoll 0.5 mg

ge healthcare as - albumin, humant, kolloidale partikler - pulver til inhalasjonsvæske til nebulisator, oppløsning - 0.5 mg

Nyxthracis (previously Obiltoxaximab SFL) Den europeiske union - norsk - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immune sera og immunglobuliner, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

MenQuadfi Den europeiske union - norsk - EMA (European Medicines Agency)

menquadfi

sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningitt, meningokokk - vaksiner - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.

Skysona Den europeiske union - norsk - EMA (European Medicines Agency)

skysona

bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - andre nervesystemet narkotika - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.